Treatment | Incremental | ||||
Results | ANA | F&A | FUL | F&A versus ANA | F&A versus FUL |
Total cost, US$ | 45 520.64 | 57 921.76 | 70 182.54 | 12 401.12 | −12 260.78 |
Overall LYs | 4.562 | 5.728 | 5.378 | 1.166 | 0.35 |
Total QALYs | 2.786 | 3.578 | 3.434 | 0.792 | 0.144 |
ICER, US$ | |||||
Per LY | 10 635.61 | −3 50 308.09 | |||
Per QALY | 15 665.89 | −85 144.33 |
F&A, half-dose fulvestrant plus anastrozole treatment group; FUL, fulvestrant;
ANA, anastrozole; LYs, life-years; QALYs, quality-adjusted life years;
ICER, incremental cost-effectiveness ratio;